Compile Data Set for Download or QSAR
Report error Found 34 Enz. Inhib. hit(s) with all data for entry = 50014454
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM50576403(CHEMBL4872605)
Affinity DataIC50: 0.360nMAssay Description:Inhibition of RET wild type (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM50576404(CHEMBL4870957)
Affinity DataIC50: 0.610nMAssay Description:Inhibition of RET M918T mutant (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM50576404(CHEMBL4870957)
Affinity DataIC50: 0.680nMAssay Description:Inhibition of RET wild type (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM435010(US10584114, Compound 130 | US11279688, Compound 13...)
Affinity DataIC50: 0.700nMAssay Description:Inhibition of RET M918T mutant (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM50576403(CHEMBL4872605)
Affinity DataIC50: 0.710nMAssay Description:Inhibition of RET V804M mutant (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM435010(US10584114, Compound 130 | US11279688, Compound 13...)
Affinity DataIC50: 0.780nMAssay Description:Inhibition of RET wild type (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM50576401(CHEMBL4845703)
Affinity DataIC50: 0.900nMAssay Description:Inhibition of RET wild type (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM50576408(CHEMBL4846521)
Affinity DataIC50: 0.900nMAssay Description:Inhibition of RET M918T mutant (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM50576400(CHEMBL4861957)
Affinity DataIC50: 1.10nMAssay Description:Inhibition of RET wild type (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM50576401(CHEMBL4845703)
Affinity DataIC50: 1.10nMAssay Description:Inhibition of RET V804M mutant (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM50576403(CHEMBL4872605)
Affinity DataIC50: 1.10nMAssay Description:Inhibition of RET M918T mutant (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM50576408(CHEMBL4846521)
Affinity DataIC50: 1.30nMAssay Description:Inhibition of RET wild type (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM50576405(CHEMBL4859281)
Affinity DataIC50: 1.40nMAssay Description:Inhibition of RET wild type (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM50576404(CHEMBL4870957)
Affinity DataIC50: 1.60nMAssay Description:Inhibition of RET V804M mutant (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM50576402(CHEMBL4875034)
Affinity DataIC50: 1.60nMAssay Description:Inhibition of RET wild type (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM435010(US10584114, Compound 130 | US11279688, Compound 13...)
Affinity DataIC50: 1.90nMAssay Description:Inhibition of RET V804M mutant (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM50576405(CHEMBL4859281)
Affinity DataIC50: 2nMAssay Description:Inhibition of RET V804M mutant (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM435010(US10584114, Compound 130 | US11279688, Compound 13...)
Affinity DataIC50: 2nMAssay Description:Inhibition of JAK2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM50576408(CHEMBL4846521)
Affinity DataIC50: 2nMAssay Description:Inhibition of RET V804M mutant (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM50576405(CHEMBL4859281)
Affinity DataIC50: 2.40nMAssay Description:Inhibition of RET M918T mutant (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM50576400(CHEMBL4861957)
Affinity DataIC50: 3nMAssay Description:Inhibition of RET M918T mutant (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM50576401(CHEMBL4845703)
Affinity DataIC50: 3.10nMAssay Description:Inhibition of RET M918T mutant (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM50576402(CHEMBL4875034)
Affinity DataIC50: 3.40nMAssay Description:Inhibition of RET V804M mutant (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM50576408(CHEMBL4846521)
Affinity DataIC50: 4.40nMAssay Description:Inhibition of JAK2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM50576400(CHEMBL4861957)
Affinity DataIC50: 5.30nMAssay Description:Inhibition of RET V804M mutant (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM435010(US10584114, Compound 130 | US11279688, Compound 13...)
Affinity DataIC50: 6.5nMAssay Description:Inhibition of FLT3 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM50576409(CHEMBL4862303)
Affinity DataIC50: 14nMAssay Description:Inhibition of RET V804M mutant (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM50576409(CHEMBL4862303)
Affinity DataIC50: 19nMAssay Description:Inhibition of RET wild type (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM50576408(CHEMBL4846521)
Affinity DataIC50: 31nMAssay Description:Inhibition of FLT3 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM50576406(CHEMBL4848545)
Affinity DataIC50: 74nMAssay Description:Inhibition of RET wild type (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM50576407(CHEMBL4859271)
Affinity DataIC50: 93nMAssay Description:Inhibition of RET wild type (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM50576409(CHEMBL4862303)
Affinity DataIC50: 96nMAssay Description:Inhibition of RET M918T mutant (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM50576407(CHEMBL4859271)
Affinity DataIC50: 129nMAssay Description:Inhibition of RET V804M mutant (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Guangzhou Baiyunshan Pharmaceutical Holdings

Curated by ChEMBL
LigandPNGBDBM50576406(CHEMBL4848545)
Affinity DataIC50: 134nMAssay Description:Inhibition of RET V804M mutant (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed